Avanz Phleum Pratense Maintenance Dose

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+ (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen induced allergic rhinoconjunctivitis with or without asthma.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ALK-Abelló A/S

Criteria

Inclusion Criteria:

• A history of grass pollen allergy

• Positive skin prick test to grass

• Positive Immunoglobulin E test to grass

Exclusion Criteria:

• Other allergies overlapping the grass pollen season

• Severe Asthma (defined as a Forced expiratory volume in 1 second (FEV1) below 70 % after adequate treatment)